Qiagen NV (WBO:QGE2)
€ 40.8 -0.54 (-1.31%) Market Cap: 9.01 Bil Enterprise Value: 9.48 Bil PE Ratio: 137.61 PB Ratio: 2.86 GF Score: 87/100

Q1 2019 Qiagen NV Earnings Call Transcript

May 07, 2019 / 01:00PM GMT
Release Date Price: €34.13 (-3.72%)
Operator

Ladies and gentlemen, thank you for standing by. I am Anna, your PGI call operator. Welcome and thank you for joining QIAGEN's conference call for -- to discuss the Q1 2019 results. (Operator Instructions) Please be advised that this call is being recorded at QIAGEN's request and will be made available on their Internet site. (Operator Instructions)

At this time, I'd like to introduce your host, John Gilardi, Vice President of Corporate Communications and Investor Relations at QIAGEN. Please go ahead.

John Gilardi
QIAGEN N.V. - VP of Corporate Communications & IR

Thank you, Anna, and welcome to all of you to our conference call. The speakers today are Peer Schatz, the Chief Executive Officer of QIAGEN; Roland Sackers, the Chief Financial Officer. Also joining us today is Phoebe Loh, a new member of our IR team, who has deep experience in the genomic testing industry and has been with QIAGEN for the last 5 years in marketing roles. Please note that this call is being webcast live and will be archived on the Investor Relations section of our website

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot